AU506539B2 - Tumour detection - Google Patents

Tumour detection

Info

Publication number
AU506539B2
AU506539B2 AU25341/77A AU2534177A AU506539B2 AU 506539 B2 AU506539 B2 AU 506539B2 AU 25341/77 A AU25341/77 A AU 25341/77A AU 2534177 A AU2534177 A AU 2534177A AU 506539 B2 AU506539 B2 AU 506539B2
Authority
AU
Australia
Prior art keywords
tumour detection
tumour
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU25341/77A
Other languages
English (en)
Other versions
AU2534177A (en
Inventor
J. R. and Thomson D. M. P Marti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU2534177A publication Critical patent/AU2534177A/en
Application granted granted Critical
Publication of AU506539B2 publication Critical patent/AU506539B2/en
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/5743Specifically defined cancers of skin, e.g. melanoma
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57411Specifically defined cancers of cervix
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57423Specifically defined cancers of lung
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57438Specifically defined cancers of liver, pancreas or kidney
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57449Specifically defined cancers of ovaries

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU25341/77A 1976-05-27 1977-05-20 Tumour detection Expired AU506539B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69045476A 1976-05-27 1976-05-27
USUS690,454 1976-05-27

Publications (2)

Publication Number Publication Date
AU2534177A AU2534177A (en) 1978-11-23
AU506539B2 true AU506539B2 (en) 1980-01-10

Family

ID=24772522

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25341/77A Expired AU506539B2 (en) 1976-05-27 1977-05-20 Tumour detection

Country Status (18)

Country Link
JP (1) JPS52145517A (sv)
AT (1) AT357690B (sv)
AU (1) AU506539B2 (sv)
BE (1) BE855063A (sv)
DE (1) DE2724114A1 (sv)
DK (1) DK233277A (sv)
ES (1) ES459164A1 (sv)
FI (1) FI771646A (sv)
FR (1) FR2352533A1 (sv)
GB (1) GB1520208A (sv)
IE (1) IE45284B1 (sv)
IL (1) IL52133A0 (sv)
LU (1) LU77413A1 (sv)
NL (1) NL7705873A (sv)
NO (1) NO771860L (sv)
NZ (1) NZ184159A (sv)
SE (1) SE7706203L (sv)
ZA (1) ZA773026B (sv)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3999944A (en) * 1975-02-28 1976-12-28 Hoffmann-La Roche Inc. Detection of breast cancer
US4043757A (en) * 1975-05-20 1977-08-23 Ortho Pharmaceutical Corporation Method for detection of human mammary carcinoma

Also Published As

Publication number Publication date
NZ184159A (en) 1979-03-28
DE2724114A1 (de) 1977-12-15
ES459164A1 (es) 1978-04-16
NO771860L (no) 1977-11-29
JPS52145517A (en) 1977-12-03
AU2534177A (en) 1978-11-23
IE45284L (en) 1977-11-27
FR2352533A1 (fr) 1977-12-23
BE855063A (fr) 1977-11-28
IE45284B1 (en) 1982-07-28
IL52133A0 (en) 1977-07-31
ZA773026B (en) 1978-04-26
FI771646A (sv) 1977-11-28
NL7705873A (nl) 1977-11-29
GB1520208A (en) 1978-08-02
FR2352533B1 (sv) 1980-06-13
DK233277A (da) 1977-11-28
SE7706203L (sv) 1977-11-28
AT357690B (de) 1980-07-25
ATA376977A (de) 1979-12-15
LU77413A1 (sv) 1978-06-26

Similar Documents

Publication Publication Date Title
AU506982B2 (en) Airin-fluid-line detector
AU519231B2 (en) Heparin-liposomes complex
AU509445B2 (en) Phathalanes
AU2329877A (en) Hentriakontapeptides
AU2350877A (en) Arylmalonamido-1-oxadethiacephalosporins
AU2289777A (en) E-2-propynyl-benzylamines
AU2268977A (en) 3-Phenyl-2-Oxazolidinones
AU503198B2 (en) Radon detection
AU2676477A (en) Surf-Ski
AU2401277A (en) Trans-hexahydro-pyrido-indoles
AU2696477A (en) Pipejoint
AU2372777A (en) Amidinoureas
AU2694177A (en) 7-b-oxyiminoacylcephalosporins
AU2464877A (en) Aminopiperidines
AU2356677A (en) Coccidiocide
AU2537677A (en) Aryltrifluoroethylamines
AU2543477A (en) 1-ARYLOXY-2-HYDROXY-3-AMINOPROPANeS
AU2370677A (en) Amidinopenicillanoyloxyalkyl amoxycillinates
AU2228277A (en) 3-deoxyanthocyanidins
AU2421077A (en) Benzoylethers
AU2428577A (en) Bis-pencillanoyloxy-alkanes
AU2556877A (en) Substicuted 2-vinyl-chromones
AU2581877A (en) Neoviridogriseins
AU1545276A (en) Shower-bathtub
AU2217377A (en) 4-deacetoxy-vincristine